Dyadic International Inc. (NASDAQ: DYAI)
$1.52
+0.0950 ( +6.69% ) 78.7K
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Market Data
Open
$1.52
Previous close
$1.42
Volume
78.7K
Market cap
$44.44M
Day range
$1.42 - $1.52
52 week range
$1.19 - $2.67
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 17 | Jul 02, 2024 |
8-k | 8K-related | 17 | Jul 02, 2024 |
4 | Insider transactions | 1 | Jun 13, 2024 |
8-k | 8K-related | 14 | Jun 11, 2024 |
4 | Insider transactions | 1 | May 23, 2024 |
10-q | Quarterly Reports | 56 | May 14, 2024 |
8-k | 8K-related | 16 | May 14, 2024 |
def | Proxies and info statements | 6 | Apr 24, 2024 |
ars | Annual reports | 1 | Apr 24, 2024 |
4 | Insider transactions | 1 | Apr 15, 2024 |